stockrowMDxHealth SA (MDXH) vs Precipio, Inc. (PRPO)
- MDxHealth SA MDXH 0.15 −6.25%
- Precipio, Inc. PRPO 19.02 −2.81%
MDxHealth SA and Precipio, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $33.3M against $14.4M — 2.3× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against 21.5%. Precipio, Inc. has the higher net margin (−4.47% vs −32.5%) and the higher return on invested capital (−7.63% vs −23.8%). Across the 17 metrics below, Precipio, Inc. leads on 10 and MDxHealth SA on 7.
Valuation
Profitability
| Metric | MDXH | PRPO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 63.23% | 44.11% | 48.32% |
| Operating margin | (18.04%) | (5.68%) | (5.68%) |
| Net margin | (32.53%) | (4.47%) | (4.10%) |
| Free cash flow margin | (5.24%) | 2.90% | 0.00% |
| Return on equity | 238.67% | (8.98%) | 0.00% |
| Return on assets | (27.38%) | (6.05%) | (6.05%) |
| Return on invested capital | (23.77%) | (7.63%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack